Sudeep Pharma Limited (SUDEEPPHRM) Share Analysis
NSE · Healthcare · Healthcare
Sudeep Pharma Limited (NSE: SUDEEPPHRM) is an Indian listed company in the Healthcare sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹1,155.00, market capitalisation ₹13,046 Cr, P/E 71.4, ROE 25.2%.
Get the AI verdict on SUDEEPPHRM: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
SUDEEPPHRM price and valuation
- Share price
- ₹1,155.00
- Market cap
- ₹13,046 Cr
- P/E ratio
- 71.4
- P/B ratio
- 14.77
- EPS
- ₹16.83
- Book value per share
- ₹78.20
- Dividend yield
- 0.13%
SUDEEPPHRM profitability and growth
- ROE
- 25.2%
- ROCE
- 28.2%
- Debt to equity
- 0.17
- Revenue growth (3 yr)
- 14%
- Revenue growth (5 yr)
- 24%
- Profit growth (3 yr)
- 40%
- Profit growth (5 yr)
- 39%
SUDEEPPHRM 52-week range
- 52-week high
- ₹1,378.00
- 52-week low
- ₹524.05
- Face value
- ₹1.00
SUDEEPPHRM shareholding pattern
- Promoters
- 76.16%
- FIIs
- 1.81%
- DIIs
- 15.64%
- Public
- 6.39%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.